diabetes mellitus, type 2
Showing NaN - NaN of 135
Diabetes, Type 2 Trial in United Kingdom (FreeStyle Libre 3 Continuous Glucose Monitoring System., Self monitoring of blood
Not yet recruiting
- Diabetes Mellitus, Type 2
- FreeStyle Libre 3 Continuous Glucose Monitoring System.
- Self monitoring of blood glucose
-
Birmingham, United Kingdom
- +16 more
Jul 12, 2023
Diabetes, Type 2 Trial (Digital Health Coaching, Food Box Delivery, Remote Patient Monitoring (RPM))
Recruiting
- Diabetes Mellitus, Type 2
- Digital Health Coaching
- +3 more
-
Birmingham, AlabamaUAB Hospital-Highlands
Feb 2, 2023
Diabetes, Type 2, Peripheral Arterial Disease Trial in Worldwide (Semaglutide, Placebo (semaglutide))
Recruiting
- Diabetes Mellitus, Type 2
- Peripheral Arterial Disease
- Semaglutide
- Placebo (semaglutide)
-
Birmingham, Alabama
- +179 more
Jan 23, 2023
Obesity, Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo)
Recruiting
- Obesity
- Diabetes Mellitus, Type 2
- Semaglutide
- Placebo
-
Birmingham, Alabama
- +73 more
Jan 24, 2023
Diabetes, Type 2, Cardiovascular Diseases Trial in United States (Intense Education Intervention)
Active, not recruiting
- Diabetes Mellitus, Type 2
- Cardiovascular Diseases
- Intense Education Intervention
-
Birmingham, Alabama
- +43 more
Jan 19, 2023
Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo (semaglutide))
Active, not recruiting
- Diabetes Mellitus, Type 2
- Semaglutide
- Placebo (semaglutide)
-
Tuscumbia, Alabama
- +393 more
Jan 17, 2023
Diabetes, Type 2 Trial in Worldwide (Oral semaglutide, Placebo (semaglutide))
Active, not recruiting
- Diabetes Mellitus, Type 2
- Oral semaglutide
- Placebo (semaglutide)
-
Birmingham, Alabama
- +73 more
Jan 13, 2023
Diabetes, Type 2, Preterm Birth, Pregnancy, High Risk Trial in Birmingham (Sliding Scale Insulin, Up-Titration of Home Insulin,
Recruiting
- Diabetes Mellitus, Type 2
- +3 more
- Sliding Scale Insulin
- +3 more
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Dec 7, 2022
Diabetes, Type 2 Trial in Worldwide (Insulin icodec, Insulin Glargine 100U/mL, Insulin Degludec)
Completed
- Diabetes Mellitus, Type 2
- Insulin icodec
- +3 more
-
Birmingham, Alabama
- +178 more
Nov 3, 2022
Diabetes, Type 2 Trial in United States (iRF System Hepatic Denervation)
Active, not recruiting
- Diabetes Mellitus, Type 2
- iRF System Hepatic Denervation
-
Birmingham, Alabama
- +7 more
Aug 10, 2022
Type2 Diabetes, Diabetes, Diabetes, Type 2 Trial in Worldwide (Tirzepatide Dose 1, Tirzepatide Dose 2, Placebo)
Recruiting
- Type2 Diabetes
- +7 more
- Tirzepatide Dose 1
- +2 more
-
Birmingham, Alabama
- +55 more
Aug 8, 2022
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, liraglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- +2 more
-
Birmingham, Alabama
- +107 more
Jul 11, 2022
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, sitagliptin, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- +2 more
-
Anniston, Alabama
- +241 more
Jul 11, 2022
Diabetes, Type 2 Trial in Worldwide (IcoSema, Semaglutide 1 mg)
Recruiting
- Diabetes Mellitus, Type 2
- IcoSema
- Semaglutide 1 mg
-
Birmingham, Alabama
- +81 more
Jun 28, 2022
Diabetes, Type 2 Trial in Worldwide (Dapagliflozin, Saxagliptin, Placebo)
Active, not recruiting
- Diabetes Mellitus, Type 2
- Dapagliflozin
- +2 more
-
Sacramento, California
- +122 more
Mar 21, 2022
Diabetes, Type 2 Trial in United States (Gan & Lee Insulin Glargine Injection, LantusĀ®)
Completed
- Diabetes Mellitus, Type 2
- Gan & Lee Insulin Glargine Injection
- LantusĀ®
-
Birmingham, Alabama
- +56 more
Mar 23, 2022
Diabetes, Type 2 Trial in United States (Semaglutide 2.4 mg, Cagrilintide 2.4 mg, Placebo (semaglutide))
Active, not recruiting
- Diabetes Mellitus, Type 2
- Semaglutide 2.4 mg
- +3 more
-
Birmingham, Alabama
- +17 more
Mar 14, 2022
Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo (semaglutide))
Completed
- Diabetes Mellitus, Type 2
- Semaglutide
- Placebo (semaglutide)
-
Birmingham, Alabama
- +128 more
Feb 14, 2022
Diabetes, Diabetes, Type 2 Trial in Worldwide (Insulin degludec, Insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- Insulin degludec
- Insulin glargine
-
Anniston, Alabama
- +228 more
Jan 6, 2022
Diabetes, Type 2 Trial in Birmingham (High-Fruit Diet)
Recruiting
- Diabetes Mellitus, Type 2
- High-Fruit Diet
-
Birmingham, AlabamaDepartment of Nutrition Sciences, University of Alabamam at Birm
Nov 30, 2021
Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, , metformin)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- liraglutide
- +2 more
-
Birmingham, Alabama
- +184 more
Jul 1, 2021
Peripheral Arterial Disease (PAD), Diabetes (DM), Diabetes, Type 1 Trial in Worldwide (REX-001, Placebo)
Recruiting
- Peripheral Arterial Disease (PAD)
- +5 more
- REX-001
- Placebo
-
Innsbruck, Austria
- +27 more
May 4, 2021
Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- liraglutide
- placebo
-
Birmingham, Alabama
- +81 more
Oct 26, 2020
Diabetes, Type 2 Trial in Worldwide (MEDI0382 low dose, MEDI0382 mid dose, MEDI0382 high dose)
Completed
- Diabetes Mellitus, Type 2
- MEDI0382 low dose
- +4 more
-
Birmingham, Alabama
- +118 more
Jul 31, 2020
Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, alpha-glucosidase inhibitors, DPP-4 inhibitors)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- liraglutide
- +6 more
-
Birmingham, Alabama
- +231 more
Jun 16, 2020